Compounded GLP-1
Where a compounded drug parts company with an FDA-approved one, where 503A parts company with 503B, and which accreditation programs tell them apart.
What is Compounded GLP-1?
A GLP-1 prepared from bulk active ingredient by a 503A or 503B pharmacy rather than bought as the approved branded product.
It is not an FDA-approved drug: no agency has reviewed that particular preparation for safety, effectiveness or manufacturing quality. This is what most sellers in this register are actually selling, and the legal ground under it narrowed sharply once the shortages closed in late 2024.
Compounded semaglutide bioequivalence →
GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.
Where Compounded GLP-1 comes up on this site
On GLP Watchdog, Compounded GLP-1 comes up in 3 research articles, 101 seller reviews, 81 FDA warning letters and 3 tools. Browse the FDA warning letters.
Research that discusses it
Tools that use it
Seller reviews that mention it
Connected terms
Other terms under Pharmacy and drug forms
Where the evidence lives
- Compounded semaglutide bioequivalence
- The full GLP-1 glossary (149 terms, 8 categories)
- Research articles — written from primary sources
- Tools and calculators
- Compare GLP-1 telehealth providers